UK, US & Canada Regulators Explain Why Decentralized Trials May Get A Closer Look

 
• By Vibha Sharma

Decentralized clinical trials are subject to the same regulatory requirements as traditional site-based trials, but are of special interest to regulators because they represent a new way of working.

Businessman find a solution to increase profit
Decentralized Trials Can Be More Complex Than Conventional Site-Based Trials • Source: Shutterstock

More from Clinical Trials

More from R&D